98%
921
2 minutes
20
Background: The impact of prenatal opioid exposure on brain development remains poorly understood.
Methods: We conducted a prospective study of term-born infants with and without prenatal opioid exposure. Structural brain MRI was performed between 40 and 48 weeks postmenstrual age. T2-weighted images were processed using the Developing Human Connectome Project structural pipeline. We compared 63 relative regional brain volumes between groups.
Results: Twenty-nine infants with prenatal opioid exposure and 42 unexposed controls were included. The groups had similar demographics, except exposed infants had lower birth weights, more maternal smoking and maternal Hepatitis C, fewer mothers with a college degree, and were more likely non-Hispanic White. After controlling for sex, postmenstrual age at scan, birth weight, and maternal education, exposed infants had significantly smaller relative volumes of the deep gray matter, bilateral thalamic ventrolateral nuclei, bilateral insular white matter, bilateral subthalamic nuclei, brainstem, and cerebrospinal fluid. Exposed infants had larger relative volumes of the right cingulate gyrus white matter and left occipital lobe white matter.
Conclusions: Infants with prenatal opioid exposure had smaller brain volumes in multiple regions compared to controls, with two regions larger in the opioid-exposed group. Further research should focus on the relative contributions of maternal opioids and other exposures.
Impact: Prenatal opioid exposure is associated with developmental and behavioral consequences, but the direct effects of opioids on the developing human brain are poorly understood. Prior small studies using MRI have shown smaller regional brain volumes in opioid-exposed infants and children. After controlling for covariates, infants with prenatal opioid exposure scanned at 40-48 weeks postmenstrual age had smaller brain volumes in multiple regions compared to controls, with two regions larger in the opioid-exposed group. This adds to the literature showing potential impact of prenatal opioid exposure on the developing brain.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110593 | PMC |
http://dx.doi.org/10.1038/s41390-020-01265-w | DOI Listing |
Womens Health Rep (New Rochelle)
August 2025
College of Nursing, Thomas Jefferson University, Phila, Pennsylvania, USA.
Objective: To describe breastfeeding behaviors and determinants in the 1-month postdelivery period among women in treatment for opioid use disorder.
Study Design: Participants completed one questionnaire during pregnancy and one questionnaire at 1 month postpartum. Those who reported on the postpartum questionnaire that they had initiated breastfeeding were included in this analysis ( = 31).
Front Hum Neurosci
August 2025
Department of Pediatrics, University of Wisconsin-Madison, Madison, WI, United States.
Amid the ongoing global substance use crisis, prenatal health research has increasingly focused on the impact of both licit and illicit substance use on fetal development, and in particular brain development. Magnetic resonance imaging (MRI) has become a critical non-invasive tool for investigating how such exposures influence the developing brain. In this review, we summarize findings from 25 peer-reviewed studies that leverage structural, functional, and diffusion MRI to examine the effects of prenatal exposure to alcohol, opioids, methamphetamines, cocaine, nicotine, or cannabis.
View Article and Find Full Text PDFFam Soc
September 2025
School of Social Work, University of Connecticut, Hartford, CT.
Researchers are referring to polysubstance use as the "fourth wave" of the opioid epidemic. Prenatal polysubstance exposure is on the rise, leading to increased health and safety complications among infants and caregivers. This study examined the co-occurrence of polysubstance exposures and child maltreatment concerns using Child Abuse and Prevention Treatment Act (CAPTA) notifications made in Connecticut.
View Article and Find Full Text PDFJ Dev Behav Pediatr
August 2025
School of Medicine, Emory University, Atlanta, GA.
Objective: A systematic review using Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines was conducted to evaluate the potential adverse impacts on neurodevelopment associated with prenatal opiate exposure.
Method: After applying exclusion criteria to the identified collection of studies, 86 studies were included in this review. Each article was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluations system.
Sci Rep
August 2025
Department of Obstetrics and Gynecology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
This study aimed to evaluate the impact of the number of psychotropic medications on short-term neonatal outcomes in pregnancies complicated by maternal psychiatric disorders, focusing on the effect of non-opioid psychotropic polypharmacy and co-exposure. A retrospective study was conducted on pregnancies complicated by maternal mental disorders that resulted in full-term singleton deliveries at a tertiary perinatal hospital between 2019 and 2023. Among 4,367 deliveries during the study period, 358 were identified.
View Article and Find Full Text PDF